Showing results (981-990 of 5,257) with videos related to

Sort By:
Pageof 526
Oncology|October 4, 2014
Cancer-related therapies at the end of life in hospitalized cancer patients from four Swiss cantons: SAKK 89/09Klazien W Matter-Walstra, Rita Achermann, Roland Rapold, et al.
Oncology|October 4, 2014
Single-lesion measurement per organ for assessing tumor response in advanced gastric cancerHyeong Su Kim, Ji Won Kim, Jung Han Kim, et al.
Oncology|September 9, 2014
The Epidermal Growth Factor Receptor Inhibitor-Related Skin Toxicity Index (EGFRISTI): a new tool for grading and managing skin adverse reactions to epidermal growth factor receptor inhibitorsPaolo Lisi, Veronica Bellini, Leonardo Bianchi
Oncology|July 12, 2014
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancerYing-Chun Shen, Chung-Pin Li, Chia-Jui Yen, et al.
Oncology|July 12, 2014
The efficacy of short-term psycho-oncological interventions for women with gynaecological cancer: a randomized studyUte Goerling, Carolin Jaeger, Annette Walz, et al.
Oncology|July 12, 2014
β-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinomaLi-Chun Lu, Yu-Yun Shao, Yi-Hsuan Lee, et al.
Oncology|October 2, 2013
Assessment of adjuvant trastuzumab-associated cardiac toxicity in korean patients with breast cancer: a single-center analysisChihwan Cha, Sung Gwe Ahn, Hak Min Lee, et al.
Oncology|January 1, 1985
Treatment of disseminated testicular tumors with combination of cis-platinum, vinblastine, bleomycin and actinomycin DA Roth, K Kolarić
Oncology|November 20, 2013
A phase II study of combined chemotherapy with 5-week cycles of S-1 and CPT-11 plus bevacizumab in patients with metastatic colon cancerTsunekazu Mizushima, Yoshito Ide, Kohei Murata, et al.
Oncology|November 8, 2014
Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies: overall results from a large cohort of patientsGiuseppe Procopio, Isabella Testa, Elena Verzoni, et al.
Pageof 526